Personalized Cardiovascular Medicine
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Mechanisms of Diseases".
Deadline for manuscript submissions: closed (15 January 2022) | Viewed by 25872
Special Issue Editor
2. Department of Preventive Cardiology and Lipidology, Medical University of Lodz, Lodz, Poland
Interests: heart failure; echocardiography; congenital heart diseases; cardiovascular diseases in pregnancy; hypertension
Special Issue Information
Dear Colleagues,
Personalized medicine is the practice of tailoring medical treatment to the individual characteristics of each patient. Personalized medicine includes identifying patients most likely to benefit and those most likely to experience adverse reactions in response to a drug, and also tailoring therapy based on pharmacokinetics or pharmacodynamic response. This Special Issue of the Journal of Personalized Medicine will highlight the current state of the art and showcase some of the latest findings in the field of personalized cardiovascular medicine. This involves the evaluation of biomarkers, expanded advanced risk factor analysis, micronutrient testing, risk scoring systems, cardiovascular genetics, gene expression testing, and non-invasive and invasive cardiovascular testing, as well as research and debate about the effectiveness of personalized medicine as a more suitable tool for the prevention and treatment of cardiovascular diseases than the traditional one-size-fits-all recommendations.
Dr. Agata Bielecka-Dabrowa
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- biomarkers
- cardiovascular diseases
- genetic testing
- proteomics
- body mass composition
- metabolomics